REDUCED INTENSITY VERSUS STANDARD MYELOABLATIVE CONDITIONING IN PATIENTS WITH ACUTE MYELOID LEUKEMIA IN SECOND COMPLETE REMISSION

被引：0
|
作者：
Terwey, T. H. [1 ]
Hemmati, P. G. [1 ]
Vuong, L. G. [1 ]
le Coutre, P. [1 ]
Massenkeil, G. [2 ]
Doerken, B. [1 ]
Arnold, R. [1 ]
机构：
[1] Charite, D-13353 Berlin, Germany
[2] City Hosp Gutersloh, Gutersloh, Germany
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2011年 / 17卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2010.12.461
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
425
引用
收藏
页码：S308 / S308
页数：1
相关论文
共 50 条
  • [21] Case-matched comparison with standard versus reduced intensity conditioning regimen in chronic myeloid leukemia patients
    Pervin Topcuoglu
    Mutlu Arat
    Muhit Ozcan
    Onder Arslan
    Osman Ilhan
    Meral Beksac
    Gunhan Gurman
    Annals of Hematology, 2012, 91 : 577 - 586
  • [22] Case-matched comparison with standard versus reduced intensity conditioning regimen in chronic myeloid leukemia patients
    Topcuoglu, Pervin
    Arat, Mutlu
    Ozcan, Muhit
    Arslan, Onder
    Ilhan, Osman
    Beksac, Meral
    Gurman, Gunhan
    ANNALS OF HEMATOLOGY, 2012, 91 (04) : 577 - 586
  • [23] Reduced-intensity transplantation in patients with acute myeloid leukemia beyond complete remission - single centre experience
    Karas, Michal
    Steinerova, Katerina
    Jindra, Pavel
    Lysak, Daniel
    Hrabetova, Marcela
    Sramek, Jiri
    BONE MARROW TRANSPLANTATION, 2018, 53 : 181 - 182
  • [24] Fludarabine and Melphalan Reduced Toxicity Versus a Myeloablative Fludarabine and Busulfan Conditioning Regimen for Acute Myeloid Leukemia
    Mathews, Vikram
    Kulkarni, Uday
    Selvarajan, Sushil
    Joshi, Nutan Damodar
    Fouzia
    Korula, Anu
    Lionel, Sharon Anbumalar
    Lakshmi, Kavitha M.
    Srivastava, Alok
    George, Biju
    Abraham, Aby
    BLOOD, 2023, 142
  • [25] Unrelated cord blood transplantation after myeloablative conditioning in adult patients with acute myeloid leukemia not in remission
    Ooi, J.
    Takahashi, S.
    Tomonari, A.
    Tojo, A.
    Asano, S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 123 - 123
  • [26] Outcome of Reduced-Intensity Allogeneic Stem Cell Transplantation for Pediatric Patients with Acute Myeloid Leukemia in Second Complete Remission in Our Institute
    Higuchi, K.
    Sato, M.
    Ioi, A.
    Mayumi, A.
    Shimizu, M.
    Sawada, A.
    Yasui, M.
    Inoue, M.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S452 - S453
  • [27] Reduced intensity conditioning allogeneic hematopoietic cell transplantation for adult acute myeloid leukemia in complete remission - a review from the Acute Leukemia Working Party of the EBMT
    Sengsayadeth, Salyka
    Savani, Bipin N.
    Blaise, Didier
    Malard, Florent
    Nagler, Arnon
    Mohty, Mohamad
    HAEMATOLOGICA, 2015, 100 (07) : 859 - 869
  • [28] Flamsa-based Reduced Intensity Conditioning Versus Myeloablative Conditioning in Patients with Relapsed/refractory Acute Myeloid Leukemia with Active Disease at the Time of Transplantation: An Alwp/ebmt Analysis
    Rodriguez-Arboli, Eduardo
    Labopin, Myriam
    Tischer, Johanna
    Brecht, Arne
    Ganser, Arnold
    Finke, Juergen
    Blau, Igor Wolfgang
    Kroeger, Nicolaus
    Kalhs, Peter
    Forcade, Edouard
    Bunjes, Donald
    Spyridonidis, Alexandros
    Savani, Bipin
    Nagler, Arnon
    Mohty, Mohamad
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 64 - 65
  • [29] Comparison of myeloablative vs reduced intensity conditioning regimens in stem cell transplantations for acute myeloid leukemia.
    Gurman, Gunhan
    Guloksuz, Gozde Aydemir
    Atilla, Erden
    Atilla, Pinar Ataca
    Bozdag, Sinem Civriz
    Yuksel, Meltem Kurt
    Toprak, Selami Kocak
    Topcuoglu, Pervin
    Ozcan, Muhit
    Arslan, Onder
    Demirer, Taner
    Akan, Hamdi
    Ilhan, Osman
    Beksac, Meral
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [30] Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes
    Scott, Bart L.
    Pasquini, Marcelo C.
    Logan, Brent R.
    Wu, Juan
    Devine, Steven M.
    Porter, David L.
    Maziarz, Richard T.
    Warlick, Erica D.
    Fernandez, Hugo F.
    Alyea, Edwin P.
    Hamadani, Mehdi
    Bashey, Asad
    Giralt, Sergio
    Geller, Nancy L.
    Leifer, Eric
    Le-Rademacher, Jennifer
    Mendizabal, Adamm M.
    Horowitz, Mary M.
    Deeg, H. Joachim
    Horwitz, Mitchell E.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (11) : 1154 - 1161
12345